Article ; Online: Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19.
2021 Volume 355, Issue 3, Page(s) e2100367
Abstract: Anti-inflammatory, specialized proresolving mediators such as resolvins, protectins, maresins, and lipoxins derived from polyunsaturated acids may play a potential role in lung diseases as they protect different organs in animal disease models. ... ...
Abstract | Anti-inflammatory, specialized proresolving mediators such as resolvins, protectins, maresins, and lipoxins derived from polyunsaturated acids may play a potential role in lung diseases as they protect different organs in animal disease models. Polyunsaturated fatty acids are an important resource for epoxy fatty acids (EET, EEQ, and EDP) that mediate a broad array of anti-inflammatory and proresolving mechanisms, such as mitigation of the cytokine storm. However, epoxy fatty acids are rapidly metabolized by soluble epoxide hydrolase (sEH). In animal studies, administration of sEH inhibitors (sEHIs) increases epoxy fatty acid levels, reduces lung inflammation, and improves lung function, making it a viable COVID-19 treatment approach. Thus, using sEHIs to activate endogenous resolution pathways might be a novel method to minimize organ damage in severe cases and improve outcomes in COVID-19 patients. This review focuses on the use of sEH inhibitors to activate endogenous resolution mechanisms for the treatment of COVID-19. |
---|---|
MeSH term(s) | Animals ; Anti-Inflammatory Agents/pharmacology ; Antiviral Agents/pharmacology ; COVID-19/immunology ; Clinical Trials as Topic ; Docosahexaenoic Acids ; Epoxide Hydrolases/antagonists & inhibitors ; Epoxide Hydrolases/physiology ; Fatty Acids, Unsaturated/pharmacology ; Humans ; SARS-CoV-2 ; COVID-19 Drug Treatment |
Chemical Substances | Anti-Inflammatory Agents ; Antiviral Agents ; Fatty Acids, Unsaturated ; resolvin D1 ; Docosahexaenoic Acids (25167-62-8) ; Epoxide Hydrolases (EC 3.3.2.-) |
Language | English |
Publishing date | 2021-11-21 |
Publishing country | Germany |
Document type | Journal Article ; Review |
ZDB-ID | 6381-2 |
ISSN | 1521-4184 ; 0365-6233 ; 1437-1014 |
ISSN (online) | 1521-4184 |
ISSN | 0365-6233 ; 1437-1014 |
DOI | 10.1002/ardp.202100367 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uf I Zs.4: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.